Leukemia Research
Volume 27, Issue 5 , Pages 375-380, May 2003

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNFα levels during treatment

  • Apostolia-Maria Tsimberidou

      Affiliations

    • Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
  • ,
  • Tracey Waddelow

      Affiliations

    • Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
  • ,
  • Hagop M Kantarjian

      Affiliations

    • Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
  • ,
  • Maher Albitar

      Affiliations

    • Department of Hematopathology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
  • ,
  • Francis J Giles

      Affiliations

    • Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-713-792-8217; fax: +1-713-794-4297.

Received 28 January 2002; accepted 23 April 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(02)00082-6

doi:10.1016/S0145-2126(02)00082-6

Leukemia Research
Volume 27, Issue 5 , Pages 375-380, May 2003